SCHEMBL1847698

SCHEMBL1847698

FC(F)(F)c1ccc(Br)cn1.OB(O)c1ccc(C(F)(F)F)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
TSHR P16473 1/20 0.44
TRPV4 Q9HBA0 1/20 0.43
MGLL Q99685 2/20 0.40
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 2/20 0.37
HDAC4 P56524 1/20 0.33
ORAI1 Q96D31 1/20 0.32
ORAI2 Q96SN7 1/20 0.32
ORAI3 Q9BRQ5 1/20 0.32
TRPV6 Q9H1D0 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ADRA2A P08913 2/20 0.32
ADRA2B P18089 2/20 0.32
ADRA2C P18825 2/20 0.32
PLAU P00749 1/20 0.32
NT5E P21589 1/20 0.31
MAP4K4 O95819 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29453607 0.89 TRPV4 (0.52) CA1CA2TSHRTRPV4MGLL
SCHEMBL249039 0.89 TRPV4 (0.52) CA1CA2TSHRTRPV4MGLL
SCHEMBL133375 0.84 TRPV4 (0.58) TRPV4ALDH1A1KDM4EHDAC4ATM
SCHEMBL3510431 0.77 CA1 (0.38) CA1CA2TSHRALDH1A1KDM4E
SCHEMBL31354845 0.75 MGLL (0.41) CA1CA2TSHRTRPV4MGLL
SCHEMBL13260557 0.72 MGLL (0.38) TRPV4MGLLORAI1ORAI2ORAI3
SCHEMBL14235111 0.71 CA2 (0.43) CA1CA2TSHRMGLLORAI1
SCHEMBL18151841 0.69 MLYCD (0.43) TRPV4ALDH1A1KDM4EATML3MBTL1
SCHEMBL2556277 0.69 ENPP2 (0.39) CA1CA2TSHRMGLLENPP2
SCHEMBL29767159 0.69 ENPP2 (0.39) CA1CA2TSHRMGLLENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2321268-A2 BI-ARYL AMINOTETRALINES F. Hoffmann-La Roche AG (CH) 2011-05-18 EP disclosed
WO-2010018113-A2 BI-ARYL AMINOTETRALINES F. HOFFMANN-LA ROCHE AG (CH) 2010-02-18 WO disclosed